Jose María González-Santos

Jose María González-Santos

Auto-generated profile, based on publicly available information

Jose María González-Santos

Cardiovascular Surgery Department, University Hospital of Salamanca, Salamanca, Spain

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2006 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
JGJuan J. Gavira
Juan J. Gavira
JHJesús Herreros
Jesús Herreros
APAna Pérez
Ana Pérez
MGMaria Garcia-Velloso
Maria Garcia-Velloso
JBJoaquín Barba
Joaquín Barba
FPFelipe Prosper
Felipe Prosper

1 June 2011 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
MDMaría José Dalmau
María José Dalmau
JGJosé María González-Santos
José María González-Santos
JBJosé Antonio Blázquez
José Antonio Blázquez
JSJosé Alfonso Sastre
José Alfonso Sastre
JLJavier López-Rodríguez
Javier López-Rodríguez
AAAntonio Arribas
Antonio Arribas
Clinical outcomes of patients undergoing aortic valve replacement may be influenced by the presence of residual gradients and patient-prosthesis mismatch. The aim of this study was to compare hemodynamic performance and clinical outcomes at 5 years after prospectively randomized porcine versus bovine aortic valve replacement. We also aimed to determine the effects of valve hemodynamics on left ventricular (LV) mass regression. A total of 108 patients undergoing aortic valve replacement were randomized to receive either the Medtronic Mosaic (MM) porcine (n=54) or the Edwards Perimount Magna (EPM) bovine pericardial prosthesis (n=54). Clinical outcomes, mean gradients, effective orifice area and LV mass regression were evaluated at 1 and 5 years after surgery. Follow-up echocardiograms were performed on 106 (98%) and 87 (92%) patients, respectively. Preoperative characteristics were similar between groups. Mean aortic annulus diameter and mean implant size were comparable in both groups. At 1 and 5 years, mean transprosthetic gradients were lower in the EPM group: EPM 10.3±3.4mmHg versus MM 16.3 ± 7.6 mmHg (p<0.0001) and EPM 9.6 ± 3.5 mmHg versus MM 16.8 ± 8.7 mmHg (p<0.0001), respectively. Similarly, indexed effective orifice areas (IEOA) at 1 and 5 years were significantly greater in the EPM group: EPM 1.10 ± 0.22 cm(2)m(-2) versus MM 0.96 ± 0.22 cm(2)m(-2) (p<0.004) and EPM 1.02 ± 0.25 cm(2)m(-2) versus MM 0.76 ± 0.19 cm(2)m(-2) (p<0.0001), respectively. At 5 years, the incidence of patient-prosthesis mismatch (IEOA ≤0.85 cm(2)m(-2)) was significantly lower in the EPM group: EPM 22.9% vs MM 73.9% (p<0.0001). Such differences were similar when analysis was stratified by surgically measured annular size and implant valve size. During the first year after surgery, both groups demonstrated similar regression of LV mass index (MM -26.3 ± 43 gm(2) vs EPM -30.1 ± 36 gm(-2); p=0.8); however, at 5 years, regression of LV mass index was significantly greater in the EPM group: (EPM -47.4 ± 35 gm(-2) vs -4.4 ± 36 gm(-2); p<0.0001). Five-year survival was 79.6 ± 4.1% in the MM group and 94.4 ± 2.2% in the EPM group (p=0.03). At 5 years, the EPM valve was significantly superior to the MM prosthesis with regard to hemodynamic performance, incidence of patient-prosthesis mismatch and regression of LV mass index. The hemodynamic superiority of the EPM prostheses in comparison to MM-prostheses demonstrated at 1 year, increased significantly over time.

1 September 1990 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
JVJ L Vallejo
J L Vallejo
JGJ M Gonzalez-Santos
J M Gonzalez-Santos
JAJ Albertos
J Albertos
MRM J Riesgo
M J Riesgo
MBM E Bastida
M E Bastida
RAR Arcas
R Arcas

1 November 1995 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
JVJosé L. Vallejo
José L. Vallejo
CMCarlos Merino
Carlos Merino
JGJosé M. González-Santos
José M. González-Santos
EBEmilia Bastida
Emilia Bastida
JAJosé Albertos
José Albertos
FDFermin González de Diego
Fermin González de Diego

19 January 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
JBJavier Bermejo
Javier Bermejo
AGAna González‐Mansilla
Ana González‐Mansilla
TMTeresa Mombiela
Teresa Mombiela
AFAna I. Fernández
Ana I. Fernández
PMPablo Martínez‐Legazpi
Pablo Martínez‐Legazpi
TIthe SIOVAC (“Sildenafil for Improving Outcomes after VAlvular Correction”) Investigators
the SIOVAC (“Sildenafil for Improving Outcomes after VAlvular Correction”) Investigators
Background: The determinants and consequences of pulmonary hypertension after successfully corrected valvular heart disease remain poorly understood. We aim to clarify the hemodynamic bases and risk factors for mortality in patients with this condition. Methods and Results: We analyzed long‐term follow‐up data of 222 patients with pulmonary hypertension and valvular heart disease successfully corrected at least 1 year before enrollment who had undergone comprehensive hemodynamic and imaging characterization as per the SIOVAC (Sildenafil for Improving Outcomes After Valvular Correction) clinical trial. Median (interquartile range) mean pulmonary pressure was 37 mm Hg (32–44 mm Hg) and pulmonary artery wedge pressure was 23 mm Hg (18–26 mm Hg). Most patients were classified either as having combined precapillary and postcapillary or isolated postcapillary pulmonary hypertension. After a median follow‐up of 4.5 years, 91 deaths accounted for 4.21 higher‐than‐expected mortality in the age‐matched population. Risk factors for mortality were male sex, older age, diabetes mellitus, World Health Organization functional class III and higher pulmonary vascular resistance—either measured by catheterization or approximated from ultrasound data. Higher pulmonary vascular resistance was related to diabetes mellitus and smaller residual aortic and mitral valve areas. In turn, the latter correlated with prosthetic nominal size. Six‐month changes in the composite clinical score and in the 6‐minute walk test distance were related to survival. Conclusions: Persistent valvular heart disease–pulmonary hypertension is an ominous disease that is almost universally associated with elevated pulmonary artery wedge pressure. Pulmonary vascular resistance is a major determinant of mortality in this condition and is related to diabetes mellitus and the residual effective area of the corrected valve. These findings have important implications for individualizing valve correction procedures. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT00862043.

1 May 2017 in Journal of Thoracic Disease
Verified
Journal Article
Closed access
PDF file
JGJosé María González-Santos
José María González-Santos
MAMaría Elena Arnáiz-García
María Elena Arnáiz-García
Dilatation of the ascending aorta (AA) is a common finding in patients with aortic valve disease. The clinical practice guidelines recommend replacing the AA whenever the diameter exceeds 45 mm. However, no consensus has been reached regarding the approach when the aorta is only moderately dilated. Although the risk in aorta replacement is generally low, it may be higher when associated with other complex surgical procedures or it is carried out in elderly patients or patients with significant comorbidity. This would justify the use of alternative surgical techniques, which reduce surgical risk and guarantee a durable correction of the aortic pathology. Conservative treatment of aneurysms of the AA via wrapping with different synthetic materials has been implemented for many years. The most commonly used technical variant is wrapping the dilated aorta with a vascular prosthesis with a predetermined diameter. When this technique is adequately applied, it immediately reduces the diameter of the AA and, to a lesser degree, the diameter of the aortic root and arch, while at the same time it reinforces the weak aortic wall. These effects lead to a drop-in wall shear stress and in the risk of aortic dissection and rupture, and persist over time. Although the low elasticity of the external support causes significant changes in the histologic structure of the aortic wall, mainly atrophy and alterations typical of a foreign body-induced reaction, this does not seem to involve a higher risk of complications. In some selected patients, this technique may be used in cases other than post-stenotic aortopathy, and also in aortas with a larger diameter.